Menu UF Health Home Menu
 
Dr. Shannon Boye
lab tour cropped
Prev Next

Retinal Gene Therapy Group

Established in 1994, AAV vectors from the RGTG were the first to:
(Click on the image to see a larger view)

Retinal Gene Therapy Timeline

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recent News

William Hauswirth receives 2014 OIS Innovator Award

Nov 11th, 2014

William Hauswirth, Ph.D. was co-awarded the 2014 OIS Innovator Award in Chicago at the Ophthalmology Innovation Summit, a full day pre-meeting of the American Academy of Ophthalmology annual meeting. He […]

Drs. Shannon Boye and Alfred Lewin each receive Individual Investigator Awards from the Foundation Fighting Blindness

Sep 12th, 2014

Dr. Boye’s grant will help support development of an AAV- based gene therapy to treat the retinal phenotype of the severe deaf/blinding disease, Usher syndrome type 1B, which is caused […]

Dr. Shannon Boye’s work on AAV vector development featured in Ophthalmology Times

Jul 24th, 2014

Dr. Shannon Boye is featured in an article from Ophthalmology Times about advances in the AAV vector for retinal gene therapy. Read the article here.

John D. Ash receives a $300,000 grant from the Foundation Fighting Blindness (FFB)

Aug 21st, 2013

John D. Ash was awarded  three year grant titled:  “Using AAV-STAT3 and AAV-PIM-1 vectors to induce broad-spectrum protection of photoreceptors and PRE” from the Foundation Fighting Blindness. This project has the […]

William Hauswirth receives the Llura Ligget Gund Award at this year’s FFB Visions Conference

Jul 2nd, 2013

The Foundation Fighting Blindness, a national non-profit organization dedicated to finding treatments and cures for blinding retinal diseases, recognizes William W. Hauswirth, Ph.D., of the University of Florida College of […]